| Property | Value |
|---|
|
?:abstract
|
-
Corona virus disease 2019 (COVID-19) epidemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has broken out with a vengeance, seriously threatening the global public health security Due to the lack of specific effective drugs, effective and positive protective measures are still the most effective ways to prevent COVID-19 Clinical studies had shown that patients with COVID-19 might develop conjunctivitis symptoms An animal experiment had also confirmed that the conjunctiva was one of the routes of SARS-CoV-2 transmission However, current studies have gotten different or even contrary conclusions, and the relationship between SARS-CoV-2 infection and the occurrence of conjunctivitis has not been elucidated Therefore, this article combines the latest clinical and animal studies to further elaborate the relationship between SARS-CoV-2 conjunctivatransmission and conjunctivitis, and explore the significance of conjunctiva transmission of SARS-CoV-2 protection Copyright 2020 by the IJO Press
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
International_Eye_Science
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
A review of research of conjunctiva transmission and conjunctivitis of SARS-CoV-2
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}